TNFRSF1A and Alzheimer disease: TfRMAb-TNFR treatment of 3xTg-AD mice for 12 weeks slightly reduced albumin (Additional file 10: Fig. S9A; p < 0.01) and potassium (Additional file 10: Fig. S9L; p < 0.05), and increased phosphorus (Additional file 10: Fig. S9H; p < 0.001) compared to the Tg-Saline mice.